Prognostic value of minichromosome maintenance mRNA expression in early-stage pancreatic ductal adenocarcinoma patients after pancreaticoduodenectomy

@article{Liao2018PrognosticVO,
  title={Prognostic value of minichromosome maintenance mRNA expression in early-stage pancreatic ductal adenocarcinoma patients after pancreaticoduodenectomy},
  author={Xiwen Liao and Chuang-ye Han and Xiangkun Wang and Ke-tuan Huang and Ting-dong Yu and Chengkun Yang and Rui Huang and Zheng-qian Liu and Quan-fa Han and Tao Peng},
  journal={Cancer Management and Research},
  year={2018},
  volume={10},
  pages={3255 - 3271}
}
Background The aim of the current study was to investigate the potential prognostic value of minichromosome maintenance (MCM) genes in patients with early-stage pancreatic ductal adenocarcinoma (PDAC) after pancreaticoduodenectomy by using the RNA-sequencing dataset from The Cancer Genome Atlas (TCGA). Methods An RNA-sequencing dataset of 112 early-stage PDAC patients who received a pancreaticoduodenectomy was obtained from TCGA. Survival analysis was used to identify potential prognostic… 
The High Expression of Minichromosome Maintenance Complex Component 5 Is an Adverse Prognostic Factor in Lung Adenocarcinoma
TLDR
The MCM5 expression is correlated with immune invasion in LUAD and may affect prognosis due to immune infiltration, and may serve as a molecular biomarker for LUAD prognosis.
UXT antisense RNA 1 sever as a novel prognostic long non-coding RNA in early stage pancreatic ductal adenocarcinoma patients after receiving pancreaticoduodenectomy
TLDR
UXT-AS1 was significantly up-regulated in pancreatic cancer tissues and identified as a novel biomarker for the prognosis of early stage PDAC, and quipazine and terazosin may be targeted drugs for UXT-as1 in PDAC.
High MCM6 Expression as a Potential Prognostic Marker in Clear-cell Renal Cell Carcinoma
TLDR
A high MCM6 expression level may be a promising biomarker to predict tumor progression, metastasis, and survival in patients with ccRCC.
Noteworthy prognostic value of phospholipase C delta genes in early stage pancreatic ductal adenocarcinoma patients after pancreaticoduodenectomy and potential molecular mechanisms
TLDR
PLCD3 may be a potential prognostic biomarker for early stage PDAC and is associated with angiogenesis, intracellular signal transduction, and regulation of cell proliferation.
Identify potential clinical significance of long noncoding RNA forkhead box P4 antisense RNA 1 in patients with early stage pancreatic ductal adenocarcinoma
TLDR
It is demonstrated that higher expression of FOXP4‐AS1 in PDAC tumor tissues were related with an inferior medical outcome and two potential targeted therapeutic drugs for it were screened.
Minichromosome maintenance protein 5 is an important pathogenic factor of oral squamous cell carcinoma
TLDR
Results suggested that minichromosome maintenance protein (MCM5) mRNA was significantly overexpressed in OSCC tissues compared with that in adjacent normal tissues, and high expression levels of MCM5 may serve as a marker for the early diagnosis of OSCC.
Genome-wide RNA-sequencing dataset reveals the prognostic value and potential molecular mechanisms of lncRNA in non-homologous end joining pathway 1 in early stage Pancreatic Ductal Adenocarcinoma
TLDR
It is indicated that LINP1 may serve as a prognostic biomarker of early stage PDAC and six small-molecule compounds including STOCK1N-35874, fenofibrate, exisulind, NU-1025, vinburnine, and doxylamine were identified as potentialLINP1-targeted drugs for the treatment of PDAC.
A Novel DNA Replication-Related Signature Predicting Recurrence After R0 Resection of Pancreatic Ductal Adenocarcinoma: Prognostic Value and Clinical Implications
TLDR
A DNA replication-related gene signature was developed to stratify the R0-treated PDAC patients with various recurrence risks and showed that the signature was closely related to cell cycle, DNA replication, and DNA repair.
MCM5 promotes tumour proliferation and correlates with the progression and prognosis of renal cell carcinoma
TLDR
MCM5 overexpression is associated with malignant status and poor prognosis in RCC, and plays an important role in proliferation and may be a potential prognostic marker and novel therapeutic target for RCC.
LACTB mRNA expression is increased in pancreatic adenocarcinoma and high expression indicates a poor prognosis
TLDR
The results elucidate that LactB is involved in the development of cancer, and that high LACTB expression in patients with PAAD can predict a poor prognosis, and was significantly related to multiple immune marker sets.
...
...

References

SHOWING 1-10 OF 109 REFERENCES
Genome-scale analysis to identify prognostic markers in patients with early-stage pancreatic ductal adenocarcinoma after pancreaticoduodenectomy
TLDR
The results have provided a new prospect for prognostic biomarkers of PDAC after pancreaticoduodenectomy, and may have a value in clinical application.
Minichromosome maintenance protein 7 is a risk factor for recurrence in patients with Dukes C colorectal cancer.
TLDR
It is found that the expression of MCM7 is an independent risk factor for RFS in patients with Dukes C colorectal cancer.
Minichromosome maintenance protein 7 as a potential prognostic factor for progression-free survival in high-grade serous carcinomas of the ovary
TLDR
The results suggest the clinical importance ofMCM7 expression in high-grade serous carcinomas of the ovary and the need for further evaluation of MCM7 as a potential prognostic factor in ovarian cancer.
The Expression and Prognostic Roles of MCMs in Pancreatic Cancer
TLDR
MCMs abnormal over-expression was significantly associated with PC progression and prognosis, and these molecules could be regarded as prognostic and therapeutic biomarkers for PC.
Minichromosome maintenance proteins 2 and 5 in non-benign epithelial ovarian tumours: relationship with cell cycle regulators and prognostic implications
TLDR
MCM-2 and MCM-5 proteins appear to be promising as prognostic markers in patients with ovarian adenocarcinomas.
Minichromosome maintenance complex component 6 (MCM6) expression correlates with histological grade and survival in endometrioid endometrial adenocarcinoma
TLDR
Evaluation of MCM6 should be considered in daily practice for risk stratification as it is a highly reproducible marker of poor prognosis in endometrial cancer.
Minichromosome maintenance protein 2 is a strong independent prognostic marker in breast cancer.
TLDR
Mcm-2 may be of utility as a prognostic marker to refine the prediction of outcome in breast cancer, for example when combined with parameters currently used in the NPI.
...
...